0001567619-20-008957.txt : 20200504
0001567619-20-008957.hdr.sgml : 20200504
20200504214516
ACCESSION NUMBER: 0001567619-20-008957
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200430
FILED AS OF DATE: 20200504
DATE AS OF CHANGE: 20200504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis George Eric
CENTRAL INDEX KEY: 0001380710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 20846663
MAIL ADDRESS:
STREET 1: C/O BIOMARIN PHARMACEUTICAL INC.
STREET 2: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2020-04-30
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001380710
Davis George Eric
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
EVP, General Counsel
Common Stock
2020-04-30
5
A
0
339
62.586
A
78181
D
Common Stock
2020-05-01
4
S
0
12504
89.380
D
65677
D
Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.
Trade made pursuant to a 10b5-1 plan executed on March 27, 2020.
/s/ Eric Fleekop, Attorney-in-Fact
2020-05-04